Eligibility criteria for EAPs generally include having a serious or life-threatening condition, such as advanced cancer, and no comparable or satisfactory alternative therapies available. Patients must also be ineligible for any clinical trials of the investigational drug and must be in a condition that justifies the potential risks associated with the treatment. The patient's healthcare provider plays a pivotal role in determining eligibility and submitting the application.
